Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice

Name: Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice
Published: 2026
License: Public Domain

Second Affiliated Hospital, Zhejiang University, School of Medicine · 2026

ClinicalTrials.gov · Datasets · License: Public Domain · 2026

Open Source ↗

ad alzheimersdisease

alzheimer disease (ad), alzheimer dementia, mci-ad, early stage alzheimer's disease, alzheimer's disease, lecanemab, different doses, observational

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Efficacy of Lecanemab at Different Therapeutic Doses for Alzheimer's Disease (AD) in Real-World Practice

Related documents